Recruiting Lung Cancer Studies in Chongqing
About Lung Cancer Clinical Trials in Chongqing
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 1 lung cancer clinical trials recruiting participants in Chongqing, CHONGQING%20MUNICIPALITY. These studies are seeking a combined 160 participants. Research is being sponsored by Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Chongqing — FAQ
Are there lung cancer clinical trials in Chongqing?
Yes, there are 1 lung cancer clinical trials currently recruiting in Chongqing, CHONGQING%20MUNICIPALITY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chongqing?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chongqing research site will contact you about next steps.
Are clinical trials in Chongqing free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chongqing studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 1 active trials in Chongqing are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov